Silence Therapeutics plc (SLNCF)

Silence Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	251	287	325	672	547	715
Market Cap Growth	25.85%	-11.59%	-51.64%	22.71%	-23.44%	17.04%
Enterprise Value	166	185	152	600	448	612
Last Close Price	2.00	2.00	2.63	1.50	3.25	7.15
PS Ratio	448.68	513.74	7.51	21.23	25.28	42.53
PB Ratio	4.03	4.61	2.42	30.54	20.58	61.93
P/TBV Ratio	4.88	5.59	2.61	57.66	33.06	580.25
P/FCF Ratio	-	-	-	-	-	96.09
P/OCF Ratio	-	-	-	-	-	77.58
EV/Sales Ratio	296.71	331.26	3.52	18.97	20.67	36.40
EV/FCF Ratio	-2.66	-	-	-	-	82.24
Debt / Equity Ratio	0.00	0.00	0.00	0.02	0.02	0.02
Debt / FCF Ratio	-	-	-	-	-	0.03
Net Debt / Equity Ratio	-1.36	-1.36	-1.10	-3.11	-3.20	-8.61
Net Debt / EBITDA Ratio	1.04	1.04	3.01	1.32	1.68	1.61
Net Debt / FCF Ratio	1.36	1.36	2.17	1.38	1.49	-13.36
Asset Turnover	0.00	0.00	0.27	0.25	0.18	0.14
Quick Ratio	8.06	8.06	10.36	4.15	4.03	5.41
Current Ratio	8.72	8.72	11.14	4.62	4.41	5.69
Return on Equity (ROE)	-90.27%	-90.27%	-58.08%	-223.22%	-273.06%	-448.22%
Return on Assets (ROA)	-30.79%	-30.79%	-19.24%	-26.32%	-26.09%	-31.44%
Return on Capital Employed (ROCE)	-69.80%	-69.80%	-26.70%	-54.00%	-49.70%	-56.50%
Earnings Yield	-35.33%	-30.86%	-13.95%	-8.07%	-9.20%	-7.46%
FCF Yield	-24.85%	-21.70%	-20.89%	-7.37%	-10.45%	1.04%
Buyback Yield / Dilution	-2.12%	-2.12%	-24.69%	-15.21%	-8.58%	-8.78%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.